OKUR · OnKure Therapeutics Inc
United States · RS rating 24 · As of 2026-11-03
| Price | 2.50 USD |
|---|---|
| 1-day change | -3.5% |
| RS rating (overall / 1M / 3M / 12M) | 24 / 45 / 14 / 33 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 6 / 33 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +9.2% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +52.6% |
| Market cap (USD) | $201.3M |